PDPN and glioblastoma: Nevertheless, since levels of circulating podoplanin have been measured in glioblastoma patients,73and podoplanin-induced platelet activation likely plays a role in thrombogenesis, the use of circulating podoplanin as a prognostic biomarker for glioblastoma-related VTE may be promising.